To understand how miR-29c increases TMZ sensitivity in glioma cells, we conducted an RNA hybrid alignment bioinformatics search and predicted a binding site for miR-29c at the position 3584-3591 of the 3′-UTR of Sp1 (Figure 4A). This evidence concerns the gene SP1 and glioma.